Pre-targeted locoregional radioimmunotheraphy with 90Y-biotin in glioma patients: Phase I study and preliminary therapeutic results

Cancer Biotherapy and Radiopharmaceuticals

Volumn 16, Issue 3, 2001, Pages 227-235

  Paganelli, G ^a   Bartolomei, M ^a   Ferrari, M ^a   Cremonesi, M ^a   Broggi, G ^b   Maira, G ^c   Sturiale, C ^d   Grana, C ^a   Prisco, G ^a   Gatti, M ^a   Caliceti, P ^e   Chinol, M ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^d BELLARIA HOSPITAL   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AVIDIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; YTTRIUM 90; YTTRIUM BIOTIN Y 90;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BLOOD TOXICITY; CANCER GRADING; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; INFECTION; MALE; MAXIMUM TOLERATED DOSE; PRIORITY JOURNAL; RADIATION DOSE; RADIOIMMUNOTHERAPY; SURGICAL TECHNIQUE; TREATMENT PLANNING;

EID: 0034959170     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/10849780152389410     Document Type: Article

References (31)

1. Brain tumor trends
2. Epidemiology of brain tumors: The national survey of intracranial neoplasms
3. Radiotherapy of primary malignant brain tumors
4. Supratentorial malignant glioma: Patterns of recurrence and implication for external-beam local treatment
5. Extraneural metastases of central nervous system tumors
6. Assumptions in the radiotherapy of glioblastoma
7. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors
8. Dosimetric properties of a novel brachytherapy balloon applicator for the treatment of maligant brain-tumor resection-cavity margins
9. Interstitial hyperthermia of malignant glioma with implant heating system
10. Intratumoral LAK cell and interleukin-2 therapy of human glioma
11. Up-front chemotherapy with fotemustine (F)/cisplatin (CDDP)/etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomas
12. Interstitial chemotherapy with mitoxantrone in recurrent malignant glioma: Preliminary data
13. The role of interstitial BCNU chemotherapy in the treatment of malignant glioma
14. Brachytherapy: Interstitial implant radiosurgery
15. Linear-accelerator radiosurgery
16. Iodine-131-labeled antitenascin monoclonal antiboy 81C6. Treatment of patients with recurrent malignant gliomas: Phase I trial results
17. Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas
18. Loco-regional radioimmunotherapy of high-grade malignant gliomas by using specific monoclonal antibodies labeled with 90Y. A phase I study
19. Role of nuclear medicine in the treatment of malignant gliomas: The locoregional radioimmunotherapy approach
20. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: Significance of elevated interstitial pressure
21. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: Loss of tumor specificity due to radiolysis
22. Pre-Targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens
23. Clinical application of the avidin-biotin system for tumor targeting
24. Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin
25. Two-step tumour targeting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin
26. The relationship of glycosylation and isoelectric point with tumor accumulation of avidin
27. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients
28. Three-step radioimmunotherapy with yttrium-90 biotin: Dosimetry and pharmacokinetics in cancer patients
29. Direct injection of 90Y MOABS into glioma tumor resection cavities leads to limited diffusion of the radioimmunoconjugates into normal brain parenchyma: A model to estimate absorbed radiation dose